(Story updated to add Cramer's Lightning Round picks, his comments on a New York Times op-ed piece on Goldman's greedy behavior and his Mad Tweets segment.) NEW YORK ( TheStreet) -- On the seventh anniversary of his "Mad Money" TV show, Jim Cramer told his viewers that they need to embrace the possibilities and opportunities of the stock market. He said it's time to come off the sidelines, sell those bank CDs earning 0.4% interest and invest in great American companies. Cramer acknowledged that investors have every right to be skeptical of the markets, especially given that the last time the averages saw these levels we were on the cusp of a horrific decline. But things are different now, as he compared the markets of 2007 versus those of today. Back in 2007, Cramer said the markets were being driven by a rise in commodities. Everything from oil to metals to fertilizer was red hot thanks to a booming Chinese economy. Meanwhile here at home, our housing market and financial system were on the brink of collapse, about to take consumer confidence with it. So where are the markets today? Cramer said today's markets are being driven by pure growth, U.S. growth. He said everything from health care to retail to technology, even the homebuilders, are just beginning to show sustainable recoveries. Stocks like JPMorgan Chase ( JPM) and IBM ( IBM), two stocks which Cramer owns for his charitable trust,
Magnificent SevenSpeculation should be an important part of every investors balance diet, Cramer told viewers, as he recapped his "Magnificent Seven" speculative stocks to show viewers just how lucrative this under-rated method of investing can be. He said that every investor should have one spot in their portfolio dedicated to a speculative stock that adds excitement to their holdings. Cramer's magnificent seven stocks included Pharmacyclics ( PCYC), a stock up 393% over the past 12 months, Medivation ( MDVN), a biotech up 320%, Idenix Pharmaceuticals ( IDIX), up 277%, and Vivus ( VVUS), up 224%. Rounding out the seven were Arctic Cat ( ACAT), which has risen 204% in 12 months, Conn's ( CONN), up 211% and HealthStream ( HSTM), which is up 192%. What can investors learn from these massive profits? Cramer said even when compared to Apple, arguably the best run company in America at the moment, speculative stocks can deliver returns that make Apple's 67% rise over the past year look passé. Whether its a revolutionary new drug, a massive takeover bid or just a strong regional to national story, like Arctic Cat, speculative stocks offer investors multiple ways to win.
Best Seven Since 2005So what have been the best stocks over the long term? Cramer also highlighted the seven best stocks that he's recommended since "Mad Money" first aired back in 2005, a list that exemplifies what "staying in the game" is all about. Cramer's top seven recommendations included Monster Beverage ( MNST), which has risen 1,600% over the past seven years, the biotech company Regeneron ( REGN), up 1,700% over seven years and Medivation ( MDVN), the only company to make both of Cramer's lists, up 1,800%. The list also included Green Mountain Coffee Roasters ( GMCR), a stock that despite huge losses recently, is still up 2,700% over seven years, SXC Health Solutions ( SXCI), up 2800%, travel site Priceline.com ( PCLN), up 2,850% and finally, Questcor Pharmceuticals ( QCOR), which has rallied an astounding 7,066% over seven years. Cramer reminded viewers that past performance doesn't guarantee future successes, but he said when companies are riding long-term trends, their successes can turn into huge gains for shareholders. He said in the case of Questcor, a $500 investment seven years ago would be worth $35,000 today.